Spirochetal Infections of the Nervous System




Keywords

Lyme disease, neuroborreliosis, neurosyphilis, spirochetes, syphilis, ticks

 


Spirochetes cause a broad range of human illnesses, including relapsing fever, yaws, pinta, leptospirosis, and periodontal disease. Although leptospirosis and relapsing fevers can cause severe headaches and myalgias in conjunction with high fever and severe systemic illness, two spirochetal infections target the nervous system specifically: syphilis and Lyme disease. Both are the subject of popular mythology and have been blamed for far more than they could possibly have done. Syphilis swept Europe at a time when medicine had yet to understand such fundamental concepts as the germ basis of infection. Even early in the twentieth century, preeminent physicians referred to syphilis as the great imitator. Notably at that time, little was understood about cerebrovascular disease or other neurologic disorders. As late as the 1950s and beyond, anecdotal reports appeared about neurosyphilis having been diagnosed on the basis of silver stains of brain tissue—a highly problematic methodology since fibrillar structures normally present in the brain stain with silver and have a corkscrew-like appearance.


Similarly, Lyme disease has been blamed for innumerable “quality-of-life” ailments. At a time when science has sequenced the human genome, can detect subtle structural abnormalities with magnetic resonance imaging (MRI), and has developed an immense and powerful pharmacopoeia, many find it difficult to accept that medicine has limitations and, in particular, cannot provide simple biologic answers to and remedies for a constellation of common and distressing symptoms, variably known over the years by terms such as neurasthenia , chronic fatigue syndrome , and fibromyalgia , among others. In this setting, some have chosen to extrapolate from the known phenomenology of Lyme disease, emphasizing the areas of similarity between these symptom complexes and Lyme disease and ignoring the far more glaring differences.


There are fascinating similarities between syphilis and Lyme disease that deserve emphasis, as they presumably reflect basic biologic properties of spirochetes. Both infections can be chronic, despite the presence of easily demonstrable antibodies targeted against major epitopes. Presumably, this relates to the spirochetal predisposition to present a limited range of surface antigens, and then change the expressed epitopes over time, as conditions require. Both disorders are spread almost exclusively by intimate contact with a vector, reflecting the very limited ability of spirochetes to survive in vitro. Both begin with prominent, angry-looking cutaneous abnormalities that are surprisingly painless, the lack of pain presumably reflecting the peculiarities of the limited local host immune response.


Both disseminate widely and rapidly, easily broaching the blood–brain barrier, probably reflecting their own inherent motility and adherence to cell-surface molecules. Both seed the nervous system frequently but cause neurologic disease only in a small subset of those seeded. Most important, both remain sensitive to fairly simple antibiotics. Although both are frequently described as presenting with protean manifestations, this reflects an approach to neurology based on phenomenology rather than pathophysiology. In fact, each infection usually causes a characteristic range of disorders. Specific manifestations in any given individual depend on the part of the nervous system involved, but the disorders are pathophysiologically related.




Syphilis


Background


Syphilis, caused by Treponema pallidum , became prominent in Europe shortly after the return of Columbus from the New World. Known at the time (in some circles) as “the French pox,” the mode of transmission was recognized early on. The Breviary of Health of 1547 states clearly that “specially it is taken when one pocky person doth synne in lechery the one with another.” At that time, as with other newly introduced infectious diseases, the morbidity and mortality associated with syphilis were high. Then, presumably as the most susceptible hosts died and the bacteria self-selected for strains that could persist without killing or incapacitating their hosts, the bacteria and humankind settled into their current symbiotic relationship. Currently, there are about 14,000 cases of primary and secondary syphilis each year in the United States.


Diagnosis


Diagnosis was originally clinical and rested on recognition of the characteristic chancre—a painless, ulcerated, indurated lesion at the site of primary infection that typically heals spontaneously. The lesion contains numerous spirochetes; one of the best methods of diagnosis is to scrape the lesion, place the scrapings in saline on a slide, and view the motile spirochetes with a dark-field microscope. In patients not seen at the time of the chancre, diagnosis initially rested on the recognition of one of the large number of clinical syndromes attributed to this disease.


More accurate diagnosis of later disease required advancements in laboratory techniques. Identification of the causative organism was an important first step, but growing T. pallidum in vitro remains essentially impossible, although inoculation into susceptible animals provides an indirect—and clinically impractical—method of propagating the organism.


The spirochete has now been very well characterized. Its length varies from 6 to 20 µm; its diameter is about 0.18 µm. It is shaped in a regular helix and exhibits corkscrew motility, propelled by its flagella. Its entire genome has now been sequenced. Despite this intimate knowledge of the spirochete, laboratory confirmation of infection, particularly after resolution of the chancre, remains dependent on serologic tests. All fall into one of two groups. Historically, screening has used indirect tests, measuring “reaginic” antibodies—in essence, anticardiolipin antibodies. The reason that patients with this infection have high titers of anticardiolipin antibody remains unknown, but presumably reflects an interaction of the spirochete with host lipoproteins and other lipids. Tests such as the Wasserman reaction, rapid plasma reagin (RPR), Venereal Disease Research Laboratory (VDRL), and Hinton tests all fall into this group. These tests have been thought to have very high sensitivity but, as indirect measures of infection, lack specificity. However, more recent work, using capture enzyme-linked immunosorbent assays (ELISAs) for comparison, suggest the reaginic tests are less sensitive than previously believed, leading to recommendations by some that direct tests be used for initial screening.


Using the still recommended approach, patients with positive reaginic test results are further tested with specific antitreponemal tests, such as the FTA-Abs (fluorescent treponemal antibody, absorbed against nonpathogenic treponemata to decrease cross-reactivity) or the MHA-TP test (microhemagglutination for T. pallidum ). Response to therapy is generally assessed by measuring titers of reaginic antibody. Typically, the serum titer in a VDRL or similar test declines steadily after successful treatment and eventually becomes negative in most cases.


When serologic testing was introduced early in the twentieth century, seroprevalence rates of 8 to 14 percent were reported in major cities. It was at that time that the medical literature blossomed, attributing all manner of disease to syphilis. It may well be that at least some of this was misattribution due to coincidentally positive serologic tests, much as occurs in Lyme disease–endemic areas today (where, coincidentally, seroprevalence rates of 5 to 15% are common).


Diagnosis of nervous system disease relies heavily on examination of the cerebrospinal fluid (CSF), which is recommended in the assessment of any patient with primary or secondary syphilis and clinical suspicion of central nervous system (CNS) involvement or with tertiary syphilis. Invasion and infection of the CNS typically result in increased protein concentration or a CSF pleocytosis, with an increased proportion of B cells. Rarely there is mild hypoglycorrhachia. Active disease typically results in presence of reaginic antibodies (VDRL) in the CSF. Chronic infection and stimulation of the immune response within the CNS generally result in increased CSF IgG concentration as well as production of oligoclonal bands. Synthesis of specific anti– T. pallidum antibody can often be demonstrated in the CSF. Successful treatment usually leads to resolution of all these abnormalities.


CSF-based diagnosis is usually straightforward but can, in some circumstances, be problematic. The CSF VDRL test is considered highly specific—a positive CSF VDRL result is regarded as diagnostic of CNS syphilis. (A CSF RPR test has far more false-positive results.) This specificity is probably related to the fact that the methodology is rather insensitive in that a fairly high concentration of antibody is needed for the test to be judged positive. Thus, the presence of a positive VDRL in the CSF is unlikely to be an artifact of contamination of CSF with peripheral blood immunoglobulin. One potential diagnostic problem arises, however, in that although the CSF VDRL typically declines after successful treatment, it may remain positive for an extended period of time. In this circumstance, the return of the CSF white blood cell count and protein concentration to normal is usually taken as evidence of adequate treatment.


With the far more technically sensitive methods used to detect actual antitreponemal antibodies (FTA-Abs, MHA-TP), contamination is a more important issue. False-positive results can occur for one of at least three reasons. Antibodies against antigenically similar organisms (e.g., Borrelia burgdorferi ) can cross-react. More important, if the lumbar puncture is traumatic, peripheral blood can contaminate the specimen, resulting in artifactual elevations in antibody titers. Probably most important, however, is the fact that some peripheral blood immunoglobulin always filters into the CSF. In the absence of CNS inflammation, there is minimal if any intrinsic production of antibodies within the CNS. However, CSF IgG concentration is typically 2 to 3 mg/dl, approximately 0.2 percent of peripheral blood IgG concentration, representing the small amount of serum immunoglobulin that normally passes through the blood–brain barrier. Just as in testing CSF Lyme serologies, standard testing conditions (diluting CSF 1:5 for the FTA-Abs, for example) are selected to compensate for this leakage. However, artifacts may arise in two important circumstances. In patients with high serum FTA-Abs titers, CSF titers may be positive simply by virtue of the small amount of specific antibody that normally filters in. Second, in the presence either of CNS inflammation or of blood–brain barrier breakdown for other reasons, the amount of peripheral blood immunoglobulin leaking into the CNS may be greater than assumed, resulting in an apparent increase in the concentration of the tested antibody but actually simply reflecting an overall and nonspecific increase in all antibody levels. These considerations notwithstanding, the CSF FTA is a highly sensitive if not entirely specific marker of neurosyphilis.


The absence of an absolute “gold standard” test for the diagnosis of neurosyphilis has resulted in controversy, differing recommendations for diagnostic strategies, and varying estimates of the sensitivity and specificity of different CSF tests. Whereas the CSF VDRL test is often said to be 100 percent specific, estimates of its sensitivity vary widely, depending on the alternative criteria used to define neurosyphilis. Screening CSF samples using the FTA-Abs and considering patients to have probable neurosyphilis if they have (1) a positive CSF FTA-Abs result, (2) a consistent clinical syndrome, and (3) elevation in either the CSF cell count, protein concentration, or both, leads to an estimated sensitivity of the CSF VDRL of 27 percent. Performing a similar analysis, but using the CSF MHA-TP as the primary criterion and comparing the CSF MHA-TP, CSF FTA-Abs, and CSF VDRL, suggests that the sensitivity of the CSF VDRL is about 40 percent, but that of the CSF MHA-TP is substantially greater than that of the FTA-Abs. However, there is evidence that as many as one-third of human immunodeficiency virus (HIV)–seronegative individuals with positive serum VDRL results will have inflammatory changes in the CSF, but no serologic (CSF VDRL or FTA-Abs) evidence of neurosyphilis, calling into doubt the assumptions underlying the first two conclusions.


Theoretically, a more definitive approach would be to determine whether antibodies targeted against T. pallidum are actually being produced within the CNS. Although a variety of techniques can be used, conceptually this is accomplished by measuring the antibody concentration in CSF and serum, normalizing for the relative total immunoglobulin concentrations in both, and determining whether specific antibody is disproportionately represented in the CSF. This approach, used in many other infections, should have very high specificity, although, again, sensitivity is difficult to define. Despite the intuitive appeal of this approach, sensitivity estimates have varied widely, depending on underlying assumptions, making its applicability uncertain at this time.


Clinical Features


After initial inoculation of spirochetes, the organism disseminates rapidly. Within weeks of infection the chancre develops at the site of infection. Chancres contain large numbers of spirochetes and are highly infectious. Untreated, they typically subside spontaneously over weeks. This early, localized disease constitutes primary syphilis. Over the ensuing few months, spirochetes disseminate, setting the stage for secondary syphilis. In this phase, there is a high antigen load, often with a significant spirochetemia. Spirochetes can invade any organ of the body but have a particular predilection for the skin (with secondary lesions, particularly involving the palms and soles), lymph nodes (particularly the epitrochlear nodes), kidney (with an immune complex–mediated glomerulonephritis), and CNS (seeded in between 25 and 40% of infected individuals). As many as 40 percent of untreated patients develop a lymphocytic meningitis. As in other basilar meningitides, the cranial nerves, particularly II to VIII, can be compromised. Intracranial pressure may be increased.


The disease then typically enters a latent phase, during which infection—and the immune response to it—persist. In the majority, the host immune response clears the infection. In a subset, late or tertiary complications develop. In some, this consists of disseminated granulomata, known as gummas, that can occur anywhere in the body, causing focal symptoms depending on location. Patients may develop gummas in the brain, causing local structural damage and symptoms. Gummas tend to be relatively benign but can be confused with neoplasms or other processes. Some patients develop an endarteritis obliterans affecting the vasa vasorum of the ascending aorta, causing characteristic aneurysmal dilatation.


Although neurologic involvement is generally divided into early or late (secondary or tertiary) manifestations, there is some variability in how different pathophysiologic entities are grouped. The acute meningitis, with or without cranial nerve involvement, typically occurs during acute spirochetal dissemination and is considered part of secondary (acute disseminated) disease. All other manifestations occur later in the disease, in what might be termed late disseminated infection (“tertiary syphilis”), although some tend to occur earlier in this “late” phase, others later.


Symptomatic nervous system involvement ultimately occurs in 4 to 6 percent of untreated patients and tends to take one of several forms. One of the earlier occurring late manifestations is meningovascular syphilis, in which the characteristic obliterative endarteritis involves the intracranial vasculature, causing strokes. Although the resultant clinical phenomena are described as protean, they are no more protean than in other cerebrovascular disease—differences reflect the site of damage, not the mechanism.


Several other characteristic abnormalities may occur. Those not due to vasculitis are collectively referred to as parenchymal neurosyphilis. Involvement of the upper brainstem and surrounding basilar cisterns may lead to Argyll Robertson pupils, small irregular pupils that do not react to light but do to accommodation. Optic atrophy may develop slowly, presumably owing to both increased intracranial pressure caused by the meningitis and local infiltration of the optic nerves. Tabes dorsalis , consisting of damage to the dorsal roots, the dorsal root ganglia, and the posterior columns, results in marked loss of proprioception, as well as “lightning-like” shooting radicular pain. Gait is typical of that in individuals with proprioceptive loss—slapping, with poor awareness of the location of the feet in space. Loss of the dorsal root ganglion neurons and dorsal roots leads to loss of reflexes and diminished pain awareness, potentially leading to repeated injuries to lower extremity joints with severe cumulative damage (Charcot joints).


One of the most fascinating disorders associated with late neurosyphilis is the late dementia, referred to as general paresis of the insane , or GPI. Initial symptoms are described as personality changes with delusions and hallucinations; seizures and myoclonus may occur. Involvement tends to be frontotemporoparietal, with a slowly progressive dementia. Considered a consequence of long-standing meningitis, the pathology is rather subtle. Inflammatory changes are seen in the ventricular walls (granular ependymitis). There is brain atrophy, ventricular enlargement, and neuronal loss, with some reactive gliosis. Parenchymal inflammation is usually rather limited, without evidence of multiple infarcts—in brief, the degree of CNS dysfunction seems out of proportion to the evidence of disease activity. MRI studies have demonstrated fairly widespread abnormalities.


Since the early 1980s, the HIV epidemic has led to a resurgence of neurosyphilis, raising new concerns about both the biology of the infection and its treatment. In HIV-infected individuals, early disease and asymptomatic disease each account for about one-third of the cases of coexisting neurosyphilis. Of patients with early disease, one-half have meningitis and one-fourth have meningovascular syphilis. Of those with late-stage disease, the majority have general paresis, and a small subset have tabes.


Finally, congenital infection still occurs. This happens most commonly during early stages of maternal infection, when spirochete dissemination is still actively occurring. Treatment during the first 4 months of gestation usually protects the fetus; after that, death of the fetus or newborn, or congenital infection, can result. The common manifestations of newborn infections include “snuffles” (rhinitis due to mucocutaneous involvement) and a diffuse rash that is unusual in that it involves the palms and soles as well as skin at mucoepithelial junctions. Involvement of the liver is common, as are osteochondritis and perichondritis, most typically manifested as a “saddle nose” and “saber shins.” Unusual, centrally notched, peg-shaped upper teeth (“Hutchinson’s incisors”) occur, as does frontal bossing. IgM assays can be useful for diagnosis.


Treatment


Treatment of early syphilis remains remarkably effective with simple regimens. Primary, secondary, and latent syphilis (without CNS involvement and of less than 1-year duration) are generally treated with a single dose of intramuscular benzathine penicillin (2.4 million units). Treatment for 2 weeks with oral doxycycline (100 mg twice daily) has been recommended for patients allergic to penicillin, although few studies have evaluated this approach; recommendations are usually for desensitization to penicillin if at all possible. When the nervous system is involved, high doses of intravenous penicillin are generally required (10 to 14 days, 3 to 4 million units every 4 hours). Curiously, for many years, weekly intramuscular injections of benzathine penicillin were used. This is still one of the recommended alternative regimens for neurosyphilis, even though the demonstrable levels in the CNS are subtherapeutic for T. pallidum , presumably reflecting the efficacy of this regimen outside the blood–brain barrier and the rather low incidence of late neurosyphilis in untreated individuals. An acceptable alternative is procaine penicillin 2.4 million units intramuscularly daily, with probenecid 500 mg orally four times daily for 10 to 14 days. Ceftriaxone has been suggested as an alternative in patients allergic to penicillin and may be useful, although few studies have demonstrated its efficacy.


Treatment has been particularly challenging in patients coinfected with HIV. Not only may syphilis cause considerably more serious symptoms, it may be much more difficult to eradicate. Patients who have received full courses of usually curative doses of intravenous penicillin have developed clear-cut relapses, even when initial treatment was at a time when the patient was not severely immunocompromised. This suggests that treatment may not eliminate these spirochetes entirely, but reduces the bacterial burden to a number that normally can be controlled by the patient’s immune system.




Lyme Disease


Background


The term Lyme disease was coined in the mid-1970s to describe a disorder affecting children living near Lyme, Connecticut, who developed what appeared to be juvenile rheumatoid arthritis. Careful epidemiologic studies demonstrated that this disorder developed following bites by hard-shelled Ixodes ticks ( Fig. 40-1 ), particularly when the bites were followed by a slowly enlarging erythroderm ( Fig. 40-2 ). It was soon recognized that this rash was identical to the one described early in the twentieth century in the European literature, known as erythema chronicum migrans (ECM or, more recently, EM), also known to develop following bites of Ixodes ticks. Similarly, by the late 1970s it became apparent that affected individuals frequently developed all or part of a neurologic triad of lymphocytic meningitis, cranial neuritis, and painful radiculoneuritis, virtually identical to the disorder described in the 1920s by two French physicians and now known as Garin–Bujadoux–Bannwarth syndrome. A German report in 1941 even associated the disorder with “rheumatism.” Although American patients appear to have more prominent rheumatologic symptoms and European patients more striking nervous system abnormalities, the European and American disorders are qualitatively similar.




Figure 40-1


Ixodes ticks.

(Reproduced courtesy of Centers for Disease Control and Prevention: http://www.cdc.gov/lyme/transmission/ ; accessed 26 February, 2013.)



Figure 40-2


Multifocal erythema migrans, extending across much of the back.


In 1982, Willy Burgdorfer isolated a novel spirochete from Ixodes ticks collected on Shelter Island, New York (directly across Long Island Sound from Connecticut), and the following year it was clearly established that this organism, named B. burgdorferi , was the agent responsible for Lyme disease. Shortly thereafter, Eva Asbrink in Sweden identified a virtually identical organism as the agent responsible for European borreliosis. Subsequent studies have permitted the subdivision of this group of Borrelia (referred to collectively as B. burgdorferi sensu lato ) into at least three subspecies. The strain responsible for North American disease has been termed B. burgdorferi sensu stricto , whereas European disease is attributed primarily to two strains, known as Borrelia garinii , responsible for most cases of neuroborreliosis, and Borrelia afzelii , responsible for several unique cutaneous abnormalities. These strain differences are believed to be responsible for the somewhat different range of presentations seen in Europe and North America.


B. burgdorferi spirochetes differ somewhat morphologically from T. pallidum. They range in length from 10 to 30 µm and are 0.2 to 0.5 µm in diameter. Like treponemes, they are helical in shape and propel themselves through medium or tissue with flagella.


Lyme disease occurs worldwide, primarily in areas in which Ixodes ticks coexist with a reservoir of infected animal hosts and potential human victims. In temperate climates the tick goes through a 2-year life cycle. After hatching into a larva ( Fig. 40-1 ), it feeds once, typically on a small mammal such as a field mouse. If this host has previously been infected, the tick may ingest spirochetes and itself become infected. After feeding, the larva matures into a nymph, which will then have its next meal. As blood enters the infected tick’s gut, spirochetes already present proliferate. Over a period of 24 to 48 hours, they migrate to the tick’s salivary glands, from which they can be injected into the new host, again transmitting infection. Because of this process, tick attachment lasting less than 24 to 48 hours is highly unlikely to result in infection.


The tick ultimately partakes of one last meal, this time as an adult. This typically occurs on a larger mammal, such as a deer, bear, or sheep—the species of choice giving rise to the popular name given the tick. Since the tick responsible for Lyme disease in the northeastern United States ( Ixodes scapularis ) is most closely associated with deer, some control strategies have focused on reducing the deer population. Although this may be helpful in lowering tick density, host elimination must be nearly complete. Similar strategies are less practical elsewhere. In much of the world, sheep provide the predominant large host. Elimination of these commercially important animals would be impractical. Other control strategies, such as providing rodents—the principal reservoir host—with acaricide-containing nesting material, springtime acaricide spraying to eliminate nymphs, and creation of dry barriers between wooded and residential areas, have met with varying success. In most endemic areas, ticks feed primarily during warmer months, placing human victims at greatest risk of contracting this infection from spring through autumn. The more temperate California climate leads to less seasonal variation.


Interestingly, although Lyme arthritis was characterized only in the 1970s, identical cases of recurrent, nontraumatic knee arthritis were recognized years earlier in eastern Long Island, where this was known as Montauk knee. Some have conjectured that Lyme disease was introduced to the United States when a herd of deer was brought to Long Island, New York, from Europe early in the twentieth century, an interesting counterpoint to the theory that Columbus imported syphilis to Europe from the New World. The disease appears to have spread slowly from Long Island to Connecticut, and then to contiguous regions, and is now endemic along much of the eastern seaboard of the United States from Massachusetts to Delaware. A second endemic focus exists in the upper Midwest, and a third in northern California. These three regions account for the vast majority of cases of Lyme disease in the United States ( Fig. 40-3 ).




Figure 40-3


Reported cases of Lyme disease in the United States, 2011. One dot is placed randomly within the county of residence for each confirmed case. Though Lyme disease cases have been reported in nearly every state, cases are reported based on the county of residence, not necessarily the county of infection.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 12, 2019 | Posted by in NEUROLOGY | Comments Off on Spirochetal Infections of the Nervous System

Full access? Get Clinical Tree

Get Clinical Tree app for offline access